Search Tag: Nevro

Executive Health Management

2023 19 Apr

Company Announces Preliminary, Unaudited Worldwide Revenue for First Quarter of 2023 of $96.3 Million and Reaffirms Full-Year 2023 Revenue and Non-GAAP Adjusted EBITDA Guidance   Nevro Corp., a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain announced that Kevin Thornal has...Read more